CDMO News and Research

RSS
Lonza nominates Juan Andres and Eric Drapé as independent Board Members

Lonza nominates Juan Andres and Eric Drapé as independent Board Members

Cell therapy commercialization: Streamline your path to cell therapy commercialization

Cell therapy commercialization: Streamline your path to cell therapy commercialization

New benchmark: 1 kg of plasmid DNA manufactured

New benchmark: 1 kg of plasmid DNA manufactured

Understanding Global Harmonization of Regulatory CMC within Veterinary Medicine with Tammy Newbold

Understanding Global Harmonization of Regulatory CMC within Veterinary Medicine with Tammy Newbold

Cellular Origins appoints Geoffrey Hodge as Non-Executive Director

Cellular Origins appoints Geoffrey Hodge as Non-Executive Director

Early feasibility studies on climate-friendly albuterol inhaler completed

Early feasibility studies on climate-friendly albuterol inhaler completed

LGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilities

LGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilities

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

Marking a vital milestone for Vertex and Charles River

Marking a vital milestone for Vertex and Charles River

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Gene Therapy Contract Development and Manufacturing: Challenges and Future Perspectives

Gene Therapy Contract Development and Manufacturing: Challenges and Future Perspectives

Vernal Biosciences Announces Partnership With REPROCELL

Vernal Biosciences Announces Partnership With REPROCELL

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

Product development and drug delivery at Seda

Product development and drug delivery at Seda

Lonza delivers strong 2022 performance with 15.1% CER sales growth and 32.1% CORE EBITDA margin

Lonza delivers strong 2022 performance with 15.1% CER sales growth and 32.1% CORE EBITDA margin

Oncodesign Services looks to the future

Oncodesign Services looks to the future

Fujifilm Europe supports World Cancer Day

Fujifilm Europe supports World Cancer Day

Charles River Laboratories: New Center Expands Cell and Gene Therapy Capabilities

Charles River Laboratories: New Center Expands Cell and Gene Therapy Capabilities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.